The American Journal of Clinical Nutrition 1997: Vol 65 Index

23 Pages·1997·7.2 MB·English

Subject Index
Volume 65
Abdominal fat tumor, MRI of, 403 Amenorrhea, lactational, complementary feeding and, 1403
Adherence to diet, 298S American Heart Association Science Advisory, Fish consumption, fish oil,
in sodium restriction, 698S lipids, and coronary heart disease, 1083
Adipose fatty acid composition, to validate dietary record, 1353S(abst) Americans
Adipose tissue. See Body fat fat intake by, 1297S(abst)
Adiposity food intake patterns of, 1264S
age and, overweight standards and, 1391 Amine, heterocyclic aromatic, in food, 1334S(abst)
visceral, in children Amino acids. See also specific amino acid
as marker for later cardiovascular disease, 1887 epinephrine and, 1765
race and, 1703 Aminotransferases, hepatic, coffee diterpenes and, 519
Adolescents Ammonia, fecal, resistant starch intake and (Letter), 167, 168
dietary assessment in, 1116S, 1138S, 1297S(abst) Amylose intake, breath-hydrogen production and, 1783
in black population, 1308S(abst) Anemia
in female athletes, 1359S(abst) delayed umbilical cord clamping and, 425
in Guam, during pregnancy, 1323S(abst) iron deficiency. See Iron deficiency anemia
in Nigeria, 1338S(abst) Angiotensin-converting enzyme inhibitors, sodium restriction and, 678S
in Norway, 1336S(abst) Anorexia nervosa
portions as indicators of, 1338S(abst) muscle function in, refeeding and, 1845
in Warsaw, 1320S(abst) weight gain in, 1034
fat intake by, 1300S(abst) Anthelminthic treatment, in preschool children, 1057
hypertension in, sodium intake and, 618S Anthropometry, maternal, infant nutrition and, in Israel, 1731
iron deficiency anemia in, in Jamaica, 831, 887 Anticonvulsants, in developmentally delayed children, vitamin D and bone
recall of distant diet as, 13!6S(abst) status in, 1042
zinc balance in, calcium intake and, 1460 Antimetabolites, optic neuropathy and, 1092(Letter), 1093(Letter)
Africa Antioxidants
children food intake in, from family common pot, 1321S(abst) atherosclerosis and, 121
dietary assessment in, 1324S(abst) cervical dysplasia risk and, 1307S(abst)
in children, 1321S(abst) in endurance athletes, 1052
infection and malnutrition in, in infants, 149 in hemodialysis patients, 844
African American population. See also Black population immune homeostasis and, 1901(Letter)
dietary assessment in, 1346S(abst) ischemic heart disease and, 1489, 1542(Editorial)
food-frequency questionnaires for, 1340S(abst) pediatric inflammatory bowel disease and, 1482
pediatric visceral fat in, 1703 in protein-energy malnutrition, in child, 1534
Age/aging. See also Geriatric population in semiquantitative food-frequency questionnaire. 1298S(abst)
cognition in, nutrition and, 20 smoking and, 562(Editorial)
energy expenditure and, 895 Apolipoprotein E phenotype, blood pressure and, 543
at introduction of complementary foods to breast-fed infants, lactational Appetite control. See Satiety
amenorrhea and, 1403 Arizona food-frequency questionnaire, for eligibility screening,
nutritional indexes and, 1721 1310S(abst)
splanchnic and whole-body leucine metabolism and, 489 Arm circumference, as measure of body composition, in children, 1709
Agricultural chemical intake, 1301S(abst) Aromatic amine and aromatic hydrocarbon, heterocyclic and polycyclic, in
Albumin synthesis, parenteral feeding and (rat), 994, 1078(Editorial) food, 1334S(abst)
Alcohol intake Aruba, dietary assessment in, 1360S(abst)
carotid intima-media thickness and, 1000 Ascariasis, iron deficiency anemia and, in Zanzibari children, 153
heart disease and, 1567 Ascorbic acid
hypertension and, 338S as biomarker of smoking-induced oxidative stress, 959
in Mediterranean population, 1324S(abst) dose-response to, smoking and, 496, 503
questionnaire for, 1314S(abst) healing effects of, 1891
Aluminum absorption (rat), 1446 Aspartame
Aluminum intake, in postmenopausal women, 803 body weight and, 409
Alzheimer disease cephalic phase insulin response to, 737
Block Health Habits and History Questionnaire in, 1364S(abst) Asthma, n—3 fatty acid ingestion and, 1011
dietary assessment in, 1307S(abst) Astronaut, energy expenditure in, 4
Am J Clin Nutr 1997;65:1905—18. Printed in USA. © 1997 American Society for Clinical Nutrition
1906 SUBJECT INDEX
Atherosclerosis smoking and, 374S
insulin resistance in Body mass index, of children, effect of diet and socioeconomic character-
Editorial, 164 istics on, 1362S(abst)
study of, 79 Body weight. See also Weight gain; Weight loss
lifestyle modification and, 1000 aspartame and, 409
thiobarbituric acid-reactive substances and antioxidants and, 121 diet and sex and, 2004S
Atherosclerosis Risk in Communities Study, 551 ideal, estimation of, in malnourished women, 1314S(abst)
Athletes, antioxidants in, 1052 sex hormones and, 1349S(abst)
Australia Bone disease, vitamin K assessment in, 883(Editorial)
dietary survey in, underreporting on, 1343S(abst) Bone mineral density
nutrition and family medicine in, 1939S after menopause, caffeine intake and, 1826
Australian Market Basket Survey, 1301S(abst) in developmentally delayed children, anticonvulsants ard, 1042
Australian National Nutrition Survey, 1337S(abst) in lactation, 1738
Avitaminosis, biochemical markers of, 951 pediatric diet and, in Saskatoon, 1344S(abst)
in premenopausal women, nutrition and, 1831
Baby boomers, food-frequency questionnaires for, 1356S(abst) of young multiethnic females, 724
Basal metabolic rate, energy intake and, 1345S(abst) Book reviews
Behavior, high-sucrose diet and, during weight loss, 908 Drug Receptor Subtypes and Ingestive Behaviour, SJ Cooper, PG
Behavioral Risk Factor Surveillance System, 1210S Clifton, 1575
Belgium, nutritional counseling and family medicine in, 1951S Handbook of Antioxidants, E Cadenas, L Packer, 579
Bioavailability of iron Handbook of Nutrition in the Aged, 2nd ed, RR Watson, 1904
in infant cereals, 916, 964 Long-term Consequences of Early Feeding, J Boulton, Z Laron, J Rey
rare earth elements and, 970 (eds), 172
Biochemical markers Nutrition, Physical Activity, and Health in Early Life, J Parizkova, 172
of chocolate intake, 1349S(abst) Nutrition and Cancer, K Griffiths, H Adlercreutz, P Boyle, L Denis, RI
in dietary assessment, 1348S Nicholson, MS Morton, 893
adipose fatty acid as, 1353S(abst) Present Knowledge in Nutrition, 7th ed, EE Ziegler, LJ Filer, 1575
calcium intake as, 1348S(abst) Scientific Basis of Vegetarianism, W Harris, 579
carotenoids as, 1350S(abst), 1353S(abst) Vitamin A Deficiency: Health, Survival, and Vision, A Sommer, KP
conceptual issues in, 1232S West Jr, 173
energy adjustment and, 1130S Weight Control: The Current Perspective, R Cottrell, 1576
food-frequency questionnaire validation by, 1348S(abst) Boron intake, in postmenopausal women, 803
in INTERSALT study, 1246S Brain development, maternal dietary polyunsaturated fatty acids and (cat),
method of triads and, 1240S 465
phylloquinone concentration as, 1351S(abst) Brazil, family medicine and nutrition in, 2010S
phytate to zinc ratio as, 1351S(abst) Breast cancer
plasma vitamin C as, 1297S(abst) chemotherapy for, reduced energy needs in, 1495
red blood cell fatty acid as, 1348S(abst), 1351S(abst), 1352S(abst) energy adjustment and, 1345S(abst)
serum carotenoids as, 1353S(abst) multinational study of, 1334S(abst)
sex hormones as, 1349S(abst) nutrition and, 1305S, 1309S(abst)
urea nitrogen as, 1353S(abst) Breast-feeding. See Infant nutrition, breast-feeding in
of fruit and vegetable intake, 1350S(abst), 1353S(abst) Breast milk. See Milk, human
of smoking-induced oxidative stress, 959 Breath hydrogen production, amylose intake and, 1783
of vitamin intake, 1349S(abst) British Dietary and Nutritional Survey, low energy reporters in,
Biotin deficiency, biotin status indicators in, 951 1342S(abst)
Biotin metabolites, in urine, 508 British men, dietary patterns in, 1365S(abst)
Birth weight, nutrition and growth and, 1339S(abst) British MRC National Survey of Health and Development, nonresponders
Black population. See also African American population to, 1341S(abst)
body composition in, in young females, 724 British National Diet and Nutrition Survey, geriatric, 1338S(abst)
in hemodialysis, antioxidant vitamii:s and carotenoids in, 844 Bulgaria, dietary assessment in, 1323S(abst)
iron deficiency anemia in, 831, 887 Bulimia nervosa, cholecystokinin release and gastric emptying in, 114
plasma 25-hydroxyvitamin D concentration in, 1349S(abst) Burn patient
Block Health Habits and History Questionnaire, in Alzheimer disease, exudative mineral losses in, 1473
1364S(abst) ornithine a-ketoglutarate metabolism in, 512
Blood lipids. See Lipid level in blood
Blood pressure. See Hypertension Cachexia, in elderly patients, cytokine activity and, 876
Body composition Caerphilly Study. See Ischemic heart disease
of children, arm circumference and triceps skinfold and, 1709 Cafestol, serum lipids and liver aminotransferases and, 519
in chronic obstructive pulmonary disease, 88 Caffeine intake. See aiso Coffee consumption
energy expenditure and, age and sex and, 895 hypertension and, 338S
in Prader-Labhart-Willi syndrome, 1369, 1540(Editorial) Calcidiol, in geriatric population, seasonal changes in, 67
of young multiethnic females, 724 Calcium, urinary, protein and salt intake and, 1465
Body fat Calcium absorption
distribution of in postmenopausal women, boron and aluminum intake and, 803
in anorexia nervosa, 1034 in premenopausal women, 798
cardiovascular disease and, 855 Calcium intake
poststarvation hyperphagia and, 717 adaptation to, 1570(Letter)
in pregnancy, 432 assessment of, 1310S(abst)
tumor in, MRI of, 403 nonheme-iron absorption and, 1820
Body mass parathyroid hormone response to, 1726
food and nutrient intake and, 366S of postmenopausal obese women, |348S(abst)
hypertension and, 338S in preschoolers, 1302S(abst)
measurement of, 203S salt-sensitive hypertension and, 712S
oral contraceptives and, 419 urinary Oxalate excretion and, 1453
SUBJECT INDEX
zinc adsorption and balance and, 1803 fatty acids and, 551
in adolescent females, 1460 lifestyle modification and, 1000
Calcium supplementation CASI. See Computer-assisted self-interviewing
bioavailability of, 1898(Letter) Cell-mediated immunity, vitamin A supplementation and, in infants, 144
in developmentally delayed children, anticonvulsants and, 1042 Central America, dietary assessment in, 1159S
iron status and, in formula-fed infant, 921 Cephalic phase, sweet taste response in, 737
Calibration-validation studies, 1142S, 1327S Cereal, for infants, iron bioavailability in, 916, 964
compliance bias in, 1327S(abst) Cervical dysplasia, antioxidant intake and, 1307S(abst)
correction of instrumental bias in, 1327S(abst) Chemical intake, agricultural, 1301S(abst)
dietitian coding and analytic variability in, 1329S(abst) Chemotherapy, reduced energy needs in, 1495
measurement errors in, 1329S(abst) Children. See Pediatric population
methods of, 1328S(abst) China
multiday data in, 1329S(abst) nationality and diet in, 1290S
population variance in, 1330S(abst) nutrient database in, 1332S(abst)
random effects model of, 1329S(abst) Chinese Americans
regression, 1179S dietary questionnaires in, 1347S(abst)
repeated, 1328S¢abst) fat intake by, 1297S(abst)
statistical design of, 1187S variety and ethnic foods in, 1365S(abst)
Cancer Chocolate intake, biochemical markers of, 1349S(abst)
antioxidants and, 1307S(abst) Cholecystokinin release
energy adjustment and, 1345S(abst) in bulimia nervosa, 114
meat preparation methods and, 1331S(abst) sucrose polyester and, 761
nutrition and, 1240S, 1295S(abst) Cholesterol. See also Lipoproteins
dietary recall and records in, 1309S(abst) coronary artery disease and
multinational study of, 1334S(abst) epidemiologic studies of, 1597S
portion size estimation in, 1312S(abst) in Norway, 1953S
questionnaire validity in, 1305S intake of
prevention of by children, 1298S(abst)
Arizona food-frequency questionnaire in, 1310S(abst) plasma lipid and lipoprotein responses to, 1747
diet and sex in, 2004S metabolism of, 1581S
Willett food-frequency questionnaire in, 1299S(abst), 1352S(abst) semiquantitative food-frequency questionnaire and, 1299S(abst)
Carbohydrate, fermentation of, during weaning, 927 soy protein reduction of, isoflavones in (Letter), 166
Carbohydrate intake Cholesterol Lowering Intervention Program (CLIP), 1297S(abst)
blood lipids and, 314S Cholesterol studies, test diets in, linoleic acid contents of, 1087(Letter),
glycogen stores and, 941 1088(Letter)
hepatic and whole-body fat synthesis and, 1774 Cholesterol-lowering diets, response variation in, 885(Editorial)
by postmenopausal women, cardiovascular risk and, 1027 Choline, carnitine homeostasis and (Letter), 574
sex hormones and, 1349S(abst) Chromium supplementation, iron metabolism and (Letter), 890, 891
Carbohydrate metabolism, fat unsaturation and, 1427 Chronic disease
y-Carboxyglutamic acid, urinary, dietary phylloquinone and, 779, 883 cachexia of, cytokine activity in, 876
Cardiovascular disease. See also Coronary heart disease; Heart disease; dietary studies in, 1159S
Hypertension; Multiple Risk Factor Intervention Trial Chronic obstructive pulmonary disease (COPD), body composition in, 88
fat distribution and, 855 Chronic renal failure
pediatric visceral fat and, 1887 insulin sensitivity in, protein intake and, 1512
risk factors for protein-energy malnutrition in, 1544
dietary therapies for, 560(Editorial) Circadian rhythms, of postprandial lipemia, 934
in postmenopausal women, 1027 CLIP. See Cholesterol Lowering Intervention Program (CLIP)
thrombotic-hemostatic factors in, 1674S, 1683S, 1687S, 1699S Coagulation factor VII, dietary fat and fiber and, in elderly population, 732
Cardiovascular function, sodium intake and, 594S Coconut oil, dietary, and hepatic storage and transport of n—3 and n—6
Caribbean population, British African, food-frequency questionnaire in, polyunsaturated fatty acids (rat), 750
1324S(abst) Coenzyme Q10, DNA damage and, in smokers, 503
Carnitine homeostasis, choline and (Letter), 574 Coffee consumption
B-Carotene hypertension and, 338S
as biomarker of fruit and vegetable intake, 1796 plasma homocysteine and, 136
in Helicobacter pylori gastritis, 101 serum lipids and liver aminotransferases and, 519
malondialdehyde concentration and, in cystic fibrosis, 575(Letter), Cognition
576(Letter) dietary assessment and, 1315S
Carotene(s) in aging population, 20
as biomarker in dietary assessment, 1130S dietary recall and
indexes of, 1269S in children, 1148S
Carotenoids in college students, 1306S(abst)
in food, 1334S(abst) food-frequency questionnaire accuracy and, 1317S(abst)
in Helicobacter pylori gastritis, 101 food-frequency questionnaire reproducibility and, 1315S(abst)
in hemodialysis patients, 844 Collaborative Multicentre Case-Control Study of Breast Cancer and Colo-
intake of rectal Cancer, 1334S(abst)
assessment of, 1302S(abst) Colon cancer
changes in, 1361S(abst) multinational study of, 1334S(abst)
lipid peroxidation and, in children with cystic fibrosis, 578(Erratum) nutrition and, 1312S(abst), 1327S(abst)
as marker of fruit and vegetable intake, 1350S(abst), 1353S(abst) Colonic fermentation capacity, in breast-fed infants, during weaning, 927
T lymphocyte responses and, 871 Commentary
Carotid artery Call for endorsement of a petition to the Food and Drug Administration
atherosclerosis in, thiobarbituric acid—reactive substances and antioxi- to always add vitamin B-12 to any folate fortification or supple-
dants and, 121 ment, 572
intima-media thickness in Dairy sensitivity, lactose malabsorption, and elimination diets in inflam-
1908 SUBJECT INDEX
matory bowel disease, 564 of adolescents, 1116S, 1138S, 1297S(abst)
Diet and serum lipid concentrations, 1893 black, 1308S(abst)
Nutrition coverage on medical licensing examinations in the United female athletic, 1359S(abst)
States, 568 pregnant, in Guam, 1323S(abst)
Communication, by new electronic media, in nutrition, 20135 in Warsaw, 1320S(abst)
Computer-assisted self-interviewing, in dietary assessment, 1275S, in Africa, 1321S(abst), 1324S(abst)
1295S(abst), 1301S(abst) in African American population, 1346S(abst)
Constipation, intestinal microflora and, inulin and lactose effects on, 1397 age and, 1721
Consumers of agricultural chemical intake, 1301S(abst)
expectations about nutritional guidance among, 1974S in Alzheimer disease, 1307S(abst)
involvement of, in nutritional issues, 1980S in American subpopulations, 1339S(abst)
Continuing Survey of Food Intakes by Individuals, 1254S, 1264S, in Aruba, 1360S(abst)
1316S(abst), 1329S(abst), 1337S(abst), 1339S(abst) of baby boomers, 1356S(abst)
food guide familiarity and, 1359S(abst) biochemical markers in, 1348S
underreporting in, 1342S(abst) adipose fatty acid as, 1353S(abst)
Contraceptives, oral, macronutrient selections and, 419 calcium intake as, 1348S(abst)
Copper, in food, 1334S(abst) B-carotene as, 1796
Copper status, low dietary copper and, 72 carotenoids as, 1350S(abst), 1353S(abst)
Corn oil, in maternal diet, offspring brain and retinal development and conceptual issues in, 1232S
(cat), 465 energy adjustment and, 1130S
Cornstarch, nocturnal, for glycogen storage disease, 1507 food-frequency questionnaire validation by, 1348S(abst)
Coronary artery disease, prevention of, diet and sex in, 2004S in INTERSALT study, 1246S
Coronary heart disease. See also Cardiovascular disease; Heart disease method of triads and, 1240S
fatty acids and, 1655S phylloquinone concentration as, 1351S(abst)
design criteria for studies of, 1590S phytate to zinc ratio as, 1351S(abst)
epidemiologic studies of, 1597S plasma fatty acid as, 1350S(abst), 1352S(abst)
fish intake and, 1083 plasma vitamin C as, 1297S(abst), 1796
nutritional counseling in, in Norway, 1953S red blood cell fatty acid as, 1348S(abst), 1351S(abst), 1352S(abst)
progression of serum carotenoids as, 1353S(abst)
diet and, 1093(Erratum) serum fatty acid as, 1350S(abst), 1354S(abst)
fatty acids and, 1088(Letter), 1090(Letter) sex hormones as, 1349S(abst)
Cox proportional hazards model, 1179S urea nitrogen as, 1353S(abst)
C-reactive protein, in protein-energy malnutrition, in child, 1534 of British men, 1365S(abst)
Cretan population, heart disease risk status in, diet and, 1882 in Bulgaria, 1323S(abst)
Cuba, optic neuropathy in, antimetabolites and, 1092(Letter), 1093(Letter) of carotenoid intake, 1302S(abst)
Cystic fibrosis in Central America, 1159S
dietary assessment in, 1304S(abst) of children, 1116S, 1148S, 1168S, 1215S, 1298S(abst)
malondialdehyde concentration in, B-carotene and (Letter), 575, 576 eating patterns in, 1358S(abst)
pediatric, lipid peroxidation in, carotenoids and, 578(Erratum) fruit and vegetable intake in, 1358S(abst)
plasma vitamin C concentration in, lung inflammation and, 1858 instruments for, 1305S
Cytokines methods of, 1307S(abst)
production of, supplementary vitamins C and E and, 1899(Letter) in Saskatoon, 1344S(abst)
in protein-energy malnutrition, in child, 1534 in China, 1290S
Czech Republic, pediatric fruit and vegetable consumption in, 1296S(abst) in Chinese American population, 1297S(abst), 1347S(abst), 1365S(abst)
classification procedures in, 1328S(abst)
Dairy fat intake, lipoprotein levels and, 1419 in CLIP, 1297S(abst)
Dairy intake, questionnaire for, 1314S(abst) cognitive influence in, 1315S
Dairy sensitivity, in inflammatory bowel disease (Commentary), 564 computer-assisted self-interviewing in, 1275S, 1295S(abst), 1301S(abst)
Daycare center, children in, dietary assessment of, 1296S(abst) correction of measurement-error bias in, 1173S
Dehydroascorbic acid, as biomarker of smoking-induced oxidative stress, in countries experiencing health transition, 1159S
959 culture-specific, 1166S, 1173S, 1320S, 1346S
Denmark in cystic fibrosis, 1304S(abst)
preventive medicine in, 2004S dietitian coding and analytic variability in, 1329S(abst)
smoking-induced oxidative stress in, biomarkers of, 959 in Egypt, 1166S
Diabetes mellitus eligibility screening in, 1310S(abst)
non-insulin-dependent, protein turnover in, 861 energy adjustment and, 1220S, 1229S, 1345S
nutritional counseling in, 1939S biochemical markers of, 1130S
risk of, n—3 fatty acid intake and, 1874 energy intake underreporting in, 1203S, 1298S(abst), 1304S(abst),
sugar alcohol intake in, metabolic response to, 947 1342S(abst)
Dialysis, protein-energy malnutrition in, 1544 epidemiologic studies of, adjustment for total energy in, 1220S, 1229S
Diarrheal mortality, in children, malnutrition and, 1070, 1080(Editorial) of fat intake, 1311S(abst)
Diet. See also specific food or group in Finland, in male smokers, 1363S(abst)
patterns of Food and Agriculture Organization initiative in, 1194S
in pancreatitis patients, 851 food and nutrient intake in. See Food and nutrient intake
sodium reduction and, 687S, 704S food choice map in, 1312S(abst)
in preventive medicine, 2004S food composition in. See Food composition
very-low-salt, adverse effects of, 671S food guide pyramid in, 1254S, 1302S(abst)
Diet and Health Knowledge Survey, 1359S(abst) food records in. See Food records
Dietary and Nutritional Survey of British Adults, low energy reporters in, food supply and, 1341S(abst)
1342S(abst) over four decades, 1153S
Dietary adherence in geriatric population, 1168S, 1282S, 1338S(abst)
in cardiology outpatients, 1306S(abst) in Puerto Ricans, 1356S(abst)
in low-fat plan, 1337S(abst) of geriatric population
Dietary assessment economic resources and, 1357S(abst)
SUBJECT INDEX
times of food consumption and food choice in, 1364S(abst) portion size training in, 1306S(abst)
in Germany, 1295S(abst) over 7 days, 1302S(abst)
in Grenada, 1166S strategies in, 1318S(abst)
in Haiti, 1339S(abst) over 24 hours, 1297S(abst), 1298S(abst)
of health-conscious diet, 1356S(abst) cholesterol level and, 1299S(abst)
in hypertension, 1312S(abst) instruments for, 1314S(abst), 1337S(abst)
INFOODS in, 1190S multiple-pass approach in, 1316S(abst)
in International Lipid Trial, 1367S(abst) telephone-administered, 1303S(abst)
interpretation of, errors in, 1100S validity of, 1344S(abst)
interview techniques in, culture-specific, 1346S(abst) in Warsaw adolescents, 1320S(abst)
in Kenya, 1166S Dietary record, of fruit and vegetable intake, 1356S(abst)
in Korea, 1361S(abst) DNA damage, smoking and, 503
local surveillance in, 1210S Dutch National Food Consumption Survey, 1300S(abst), 1360S(abst)
meal quality and patterns in, 1360S(abst)
measurement errors in, 1329S(abst) Eating disorders. See also specific disorder
of Mediterranean population, 1282S, 1366S(abst) estimating ideal body weight in, 1314S(abst)
methods of, 1307S(abst), 1361S(abst) Economic resources, dietary variety and, 1357S(abst)
in culturally diverse populations, 1346S(abst) Editorial
in Mexico, 1159S Ascorbic acid: hype, hoax, or healer?, 1891
iil minority populations, 1108S Better understanding of folate nutrition through chemistry, 162
multiday data in, 1329S(abst) Cigarette smoking and antioxidant vitamins, 562
National Health and Nutrition Examination Survey III in, 1203S Contemporary implications of an African legacy: the lesser red cell mass
in Native Americans, 1173S in black West Indians, 887
in Nepal, 1322S(abst) A distinctive obesity: body composition provides the clue, 1540
new developments in, 1295S Efficacy of multiple dietary therapies in reducing cardiovascular disease
in Niger, 1320S(abst) risk factors, 560
in Nigeria, 1321S(abst), 1331S(abst) Flavonoids and heart disease, 1542
nonresponders to, 1341S(abst) Improved functional endpoints for use in vitamin K assessment: impor-
in obesity, 1304S(abst), 1305S(abst) tant implications for bone disease, 883
in Pacific Islands, 1346S(abst) Insulin resistance in atherosclerosis, 164
picture-sort approach in, 1123S, 1296S(abst) Two new ventures, 1082
from Polyp Prevention Trial, 1340S(abst) Understanding the basis for variation in response to cholesterol-lowering
in Puerto Rico, 1356S(abst) diets, 885
in refugee camps, 1338S(abst) Visceral fat mass in childhood: a potential early marker for increased
repertory-grid technique in, 1318S(abst) risk of cardiovascular disease, 1887
retrospective, 1318S(abst) Zinc deficiency in young children, 160
in Russia, 1367S(abst) Education, on nutrition
pediatric, 1215S certification in, 1562
systems for, 1337S(abst) for family physicians, 2007S, 2010S, 2013S
SENECA findings in, 1282S in medical school, 1558, 1559
in Sweden, 1305S(abst), 1362S(abst) by new electronic media, 2013S
methods of, 1308S(abst) Egg(s), dietary, human milk B-lactoglobulin and ovalbumin content and,
validity of, 169(Letter), 1138S 30
biochemicai markers in, 1130S, 1232S, 1240S, 1246S Egypt, dietary assessment in, 1166S
calibration-validation in. See Calibration-validation studies Elderly persons. See Geriatric population
cholesterol levels and, 1299S(abst) Electronic media, in nutrition education, 2013S
discriminant, 1269S End-stage liver disease, in child, transplantation for, long-term growth
in Germany, 1295S(abst) after, 534
in hypertension, 1312S(abst) Endurance exercise, antioxidant supplementation and, 1052
methods of determining, 1300S(abst) Energy adjustment
plasma vitamin C in, 1297S(abst) in dietary assessment, 1220S, 1229S, 1345S
profile method and, 1307S(abst) biochemical markers of, 1130S
regression calibration in, 1179S exposure assessment rate and, 1345S(abst)
statistical design and, 1187S multicriterial assessment and, 1345S(abst)
Dietary Behavior Questionnaire, fat and fiber intake on, 1367S(abst) Energy balance, oral contraceptives and, 419
Dietary Effects of Lipoproteins and Thrombogenic Activity (DELTA) Energy expenditure
Study, 1366S(abst) age and, 895
Dietary Guidelines for Americans, baby boomer compliance with, in dietary assessment, 1130S, 1138S
1356S(abst) food intake and, 941
Dietary Habits Questionnaire, 1359S(abst) in male astronauts, 4
Dietary history during recovery from malnutrition, 1517
energy intake underestimation on, by elderly women, 1343S(abst) sex and, 895
validity of, 1339S(abst) nergy intake. See also Food and nutrient intake
Dietary recall in adolescents, 1138S
biasing estimates in, social desirability of, 1316S(abst) in chemotherapy, 1495
calibration studies and, 1187S on dietary history, 1339S(abst)
in children, 1116S, 1148S, 1296S(abst), 1298S(abst) fat percentage in, 1359S(abst)
cognitive processing in, in children, 1148S food guide pyramid in, 1254S
in college students, 1306S(abst) how children remember, 1148S
distant, reproducibility of, 1316S(abst) implausibly low, 1360S(abst)
in elderly, 1315S(abst) multicriterial assessment of, 1345S(abst)
food photographs in, 1310S(abst) overreporting of, 1304S(abst)
over four decades, 1153S sensory properties of fat and, 1375
pictorial, 1296S(abst) studies of, compliance bias in, 1327S(abst)
1910 SUBJECT INDEX
total, adjusting for, 1220S, 1229S low, assessment of, 1363S(abst)
underreporting of, 1203S, 1298S(abst), 1304S(abst), 1342S(abst) malabsorption of, fatty acid deficiency and, 837
in Australia, 1343S(abst) modification of, 1361S(abst)
in elderly, 1343S(abst) in the Netherlands, 1360S(abst)
Enteral feeding pediatric, recall of, 1298S(abst)
fiber-supplemented, intestinal transit time and, 1840 percentage of energy from, 1359S(abst)
glutamine in, parenteral versus, 977 plasma lipid and lipoprotein responses to, 1747
ornithine a-ketoglutarate metabolism after, in burn patient, 512 population characteristics and, 1368S(abst)
Epinephrine, amino acid utilization and, 1765 by preschoolers, 1302S(abst)
Errata, 578, 1093 recall of, over 7 days, 1302S(abst)
Erythrocyte peroxidation, vitamin E and ascorbate concentration and, red blood cell fatty acid as marker of, 1348S(abst), 1351S(abst),
smoking and, 496, 503 1352S(abst)
Ethnicity. See also specific group or country reduction of
antioxidant vitamins and carotenoids in, in hemodialysis, 844 in females, 1867
body composition and, in young females, 724 validation of, 1365S(abst)
food-frequency questionnaires and, 1108S, 1340S(abst) satiety and, 1410
in adolescents, 1308S(abst) saturation of, LDL concentration and metabolism and, 1617S, 1628S
in geriatric group, 1307S(abst) self-administered food-frequency questionnaire for, 1306S(abst)
iron deficiency anemia and, 831, 887 serum fatty acid as marker of, 1350S(abst), 1354S(abst)
pediatric visceral fat and, 1703 studies of, compliance bias in, 1327S(abst)
plasma 25-hydroxyvitamin D concentration and, 1349S(abst) in Sweden, 1308S(abst)
Eurocode, 1282S Fat substitute, sensory properties of, energy intake and, 1375
European Prospective Investigation into Cancer and Nutrition (EPIC), Fatty acids. See also Cholesterol, Lipoproteins
1240S, 1295S(abst) adipose, to validate dietary record, 1353S(abst)
EVA Study, 121 carotid artery wall thickness and, 551
Exercise coronary artery disease and, 1655S
age-neutral, overweight standards and, 1391 design criteria for studies of, 1590S
bone density and, postmenopausal caffeine intake and, 1826 epidemiologic studies of, 1597S
chemotherapy and, energy intake and, 1495 progression of, 1088(Letter), 1090(Letter)
maintaining diary of, 1297S(abst) deficiency of, fat malabsorption and, 837
postprandial lipemia and, in middle-aged women, 525 hemostasis and, 1674S, 1683S, 1687S, 1699S
a=3
Familial hypercholesterolemia, in children, diet and, 1018 asthma and, 1011
Family medicine coronary heart disease and, 1083
dietary intervention in diabetic risk and, in hyperlipidemia and glucose intolerance, 1874
in Australia, 1939S in pregnancy, 1351S(abst)
effectiveness of, 1933S serum lipoproteins and, 1611S, 1645S, 1655S
morbidity in, 1928S and urinary nitric oxide metabolite excretion, 459
nutritional counseling in, 2020S n—3 and n—6
in Belgium, 1951S FDA perspectives of, 1578S
in Brazil, 2010S hepatic storage and transport of (rat), 750
consumer expectations about, 1974S in plasma, as marker of fat intake, 1350S(abst), 1352S(abst)
education by media in, 2013S platelet function and, 1665S
in Germany, 1957S polyunsaturated
information sources and strategies in, 1996S hepatic storage and transport of (rat), 750
in Italy, 1963S retinal and brain accretion of, in developing felines, 465
long-term effect of, 1946S in red blood cells, as marker of fat intake, 1348S(abst), 1351S(abst),
in the Netherlands, 1967S, 1996S 1352S(abst)
in Norway, 1953S seasoning consumption and, 1309S(abst)
physician attitudes toward, 2016S short-chain, in breast-fed infants, 927
physician education in, 2007S, 2010S, 2013S thrombosis and, 1674S, 1683S, 1687S, 1699S
prevention in trans
in Denmark, 2004S FDA perspectives of, 1578S
in the Netherlands, 1943S lipoprotein levels and, 1419
Fasting Hyperglycaemia Study, 1299S(abst) unsaturation degree of
Fat LDL concentration and metabolism and, 1617S, 1628S
FDA perspectives of, 1578S postmeal metabolism and, 1427
hepatic and whole-body synthesis of, carbohydrate overfeeding and, Fecal ammonia concentration, resistant starch intake and (Letter), 167, 168
1774 Fenitrothion intake, 1301S(abst)
oxidation of, GH and IGF-I and, 1384 Fermented foods, intake of, 1362S(abst)
Fat intake Ferritin, biological variation of, 1897(Letter)
in adolescents, adults, and elderly people, 1300S(abst) Fiber intake
apolipoprotein E phenotype and, blood pressure and, 543 assessment of, 1310S(abst)
by Chinese Americans, 1297S(abst), 1365S(abst) blood lipids and, 327S
coagulation factor VII and, in elderly population, 732 coagulation factor VII and, in elderly population, 732
dairy, lipoprotein levels and, 1419 dietary behavior questionnaires for, 1367S(abst)
dietary behavior questionnaires for, 1367S(abst) in enteral formula, intestinal transit time and, 184)
dietary compliance in, 1337S(abst) hypercholesterolemia and, 107
by hypercholesterolemic children, 1357S(abst) hypertension and, 338S
identification and characterization of, 1340S(abst) polyp prevention and, 1340S(abst)
indexes of, validity of, 1311S (abst) in Sweden, 1308S(abst)
insulin resistance and, 79 VLDL lipoprotein metabolism and (guinea pig), 814
ischemic heart disease risk and, in postmenopausal women, 1027 Fibrinolysis, plasma lipids and, 1669S
in Korea, 1323S(abst) Filipino population, dietary assessment interviews in, 1346S(abst)
SUBJECT INDEX
Finland, dietary patterns in, in male smokers, 1363S(abst) selenium, copper, and carotenoids in, 1334S(abst)
Fish intake, coronary heart disease and, 1083 US Department of Agriculture databases of, 1331S(abst)
Fish oil Food groups
diabetic risk and, in hyperlipidemia and glucose intolerance, 1874 intake of, cross-cultural variations in, 1282S
garlic supplementation with, in hypercholesterolemia, 445 recommended intake of, 209S
serum lipoproteins and, 1611S, 1645S, 1655S Food guide pyramid, 1254S
urinary nitric oxide metabolite excretion and, 459 for preschoolers, 1302S(abst)
Flavonols, ischemic heart disease and, 1489, 1542(Editorial) Food insecurity, Radimer-Cornell measures of, 1341S(abst)
Folic acid Food records. See also Dietary recall
deficiency of, p53 gene and, 46 chemical analysis and, 1332S(abst)
metabolism of consecutive- versus alternate-day collection of, 1312S(abst)
kinetics of, 53 of hypertensive patient, 1312S(abst)
understanding of, through chemistry, 162(Editorial) minimum required, 1327S(abst)
supplemental, vitamin B-12 in (Commentary), 572 portions on, 1313S(abst)
unmetabolized, in serum, 1790 Food-frequency questionnaires. See also Dietary assessment
Food and Agriculture Organization, food composition initiative of, 1194S for adolescents, 1018, 1116S, 1296S(abst), 1300S(abst), 1311S(abst)
Food and Drug Administration (FDA), fat and fatty acid perspectives of, in Norway, 1336S(abst)
1578S alternative, for low-income women and children, 1311S(abst)
Food and nutrient intake. See also specific food or food group antioxidant intake on, cervical dysplasia risk and, 1307S(abst)
adequacy of, 1356S(abst) Arizona, 1310S(abst)
from African family common pot, 1321S(abst) for baby boomers, 1356S(abst)
attitudes toward, in United Kingdom, 1985S biochemical validation of, 1348S(abst)
changes motivators in, among women, 1362S(abst) for biracial elderly population, 1307S(abst)
cross-cultural variations in, 1282S Block, in Alzheimer disease, 1364S(abst)
in elderly, 1304S(abst), 1316S(abst) in British African Caribbean population, 1324S(abst)
estimating distribution of, 1330S(abst) calibration of, 1328S(abst)
by female adolescent athletes, 1359S(abst) for children, 1018, 1116S, 1296S(abst), 1307S(abst)
fermented foods in, 1362S(abst) low-income, 1311S(abst)
food choice map in, 1312S(abst) in Chinese American population, 1347S(abst), 1365S(abst)
food records and, 1332S(abst) classification procedures in, 1328S(abst)
by geriatric population, timing of and food choices in, 1364S(abst) cognitive interviewing and, 1317S(abst)
glycogen stores and, 941 culturally competent, 1166S
in healthy adult volunteers, 1355S(abst) diet records and, 1305S
indexes of, validity of, 1269S discriminant validity of, 1269S
in Kuwait, 1355S(abst) for elderly, 1300S(abst), 1304S(abst)
marketing research of, 1336S(abst) validity of, 1311SF(abst)
measurement errors in, 1329S(abst) vitamin intake and, 1349S(abst)
nationality and, in China,- 1290S for eligibility screening in clinical trials, 1310S(abst)
in the Netherlands, 1360S(abst), 1967S, 1996S ethnicity and, 1108S, 1340(abst)
patterns of, 1355S in adolescents, 1308S(abst)
in American adults, 1264S in geriatric group, 1307S(abst)
in children, 1358S(abst) in Fasting Hyperglycaemia Study, 1299S(abst)
in China, 1290S fat and salt intake reduction on, 1365S(abst)
in Czech Republic, 1296S(abst) French, validation of, 1325S(abst)
portions in, software for, 1358S(abst) fruit and meat intake on, 1367S(abst)
recommendations for, familiarity with, 1359S(abst) fruit and vegetable intake on, 1356S(abst)
in rural Morocco, 1355S(abst) for Hassidic Jews, 1325S(abst)
of Saskatoon children, 1344S(abst) Helen Keller international, 1320S(abst)
seasonings and, 1309S(abst) for Hispanic population, 1340S(abst), 1363S(abst)
serum lipid concentration and, 1329S(abst) inclusion of recipes and commercial products in, 1300S(abst)
snacks as, 1355S(abst) in Korea, 1323S(abst)
Food and nutrition surveillance, 1198S, 1336S, 1341S(abst). See also low-fat intake on, 1363S(abst)
Food-frequency questionnaires machine-readable, 1295S(abst}
in Nigeria, 1336S(abst) in minority populations, 1108S
in Russia, 1215S as motivator for change, 1364S(abst)
for states and communities, 1210S multinational, 1334S(abst)
underreporting in, 1203S, 1298S(abst), 1304S(abst), 1342S(abst) in Nigeria, 1336S(abst)
in Australia, 1343S(abst) picture-sort approach in, 1123S
Food availability, household-budget surveys and, 1343S(abst) plasma vitamin D concentration and, 1349S(abst)
Food choice map, 1312S(abst) portions on, 1313S(abst)
Food composition, 1331S portion-size differences on, 1342S(abst)
analysis of, priorities in, 1333S(abst) in pregnancy, fatty acid intake on, 1351S(abst)
on balance sheets, 1332S(abst) for Puerto Rican and non-Hispanic adults, 1325S(abst)
in China, 1332S(abst) quantitative, for adolescent Norwegians, 1336S(abst)
codes for, 1333S(abst) in refugee camps, 1338S(abst)
data banks of, 1332S(abst), 1333S(abst) repeated, 1328S(abst)
Food and Agriculture Organization initiative in, 1194S reproducibility of, 1315S(abst)
heterocyclic aromatic amine and polycyclic aromatic hydrocarbon in, self-administered
1334S(abst) for adolescents, 1311S(abst)
INFOODS database of, 1190S fat intake on, 1306S(abst)
international interface standards for, 1332S(abst) nutritionist review of, 1296S(abst)
meat preparation and, 1331S(abst) semiquantitative
in Nigeria, 1331S(abst) for adolescents, adults, and elderly people, 1300S(abst)
plant bioactive compounds in, 1334S(abst) cholesterol level and, 1299S(abst)
1912 SUBJECT INDEX
for elderly, 1304S(abst) Health Habits and History Questionnaire (HHHQ), 1313S(abst)
response rates to, 1303S(abst) Health-conscious diet, adequacy of, 1356S(abst)
in Sweden, 1308S(abst) Healthy People 2000, 1254S
in Swedish elderly, 1311S(abst) Heart disease. See also Cardiovascular disease; Coronary heart disease
vitamin A assessment in, 1298S(abst) alcohol and, 1567
statistical design of, 1187S Cretan, study of, 1882
in Taiwan, 1322S(abst) ischemic. See Ischemic heart disease
underreporting in, 1203S, 1298S(abst), 1304S(abst) Helen Keller International food-frequency method, 1320S(abst)
identifying patterns in, 1317S(abst) Helicobacter pylori gastritis, carotenoids and vitamin E in, 101
validity of, 1130S, 1138S, 1298S(abst), 1307S(abst) Hemodialysis
biochemical markers of, 1130S antioxidant vitamins and carotenoids in, 844
fat intake and, 1300S(abst) glucose turnover and oxidation in, 128
nutritionist review of, 1296S(abst) Hemostasis, fatty acids and, 1674S, 1683S, 1687S, 1699S
vitamin intake and, 1349S(abst) Hemostatic factors, in cardiovascular disease, 1674S, 1683S, 1687S, 1699S
Willett, in cancer prevention studies, 1299S(abst), 1352S(abst) Hispanic Health Nutrition Examination Survey
Formula feeding. See Infant nutrition, formula feeding in diet quality and acculturation in, 1356S(abst)
Framingham Children’s Study, 1307S(abst) portions on, 1342S(abst)
France Hispanic population
food-frequency questionnaire in, validation of, 1325S(abst) body composition in, in young females, 724
fruit and vegetable intake in, biochemical markers of, 1796 food-frequency questionnaires for, 1340S(abst), 1363S(abst)
Fruit intake Holistic medicine, nutritional counseling in, 1957S, 1967S
carotenoid as marker of, 1350S(abst), 1353S(abst) Homocysteine, total plasma, coffee consumption and, 136
by children, 1358S(abst) Hookworms, iron deficiency anemia and, in Zanzibari children, 153
on food-frequency questionnaire, 1356S(abst), 1367S(abst) Hordaland Homocysteine Study, 136
pediatric, in Czech Republic, 1296S(abst) Hospital readmission, in geriatric population, 1714
polyp prevention and, 1340S(abst) Household budget surveys, food availability on, 1343S(abst)
serum B-carotene and vitamin C as markers of, 1796 Human Nitrition Information Service, 1331S(abst), 1333S(abst)
Hunger, Radimer-Cornel! measures of, 1341S(abst)
Garlic, fish oil supplementation with, in hypercholesterolemia, 445 Hydrocarbon, polycyclic aromatic, in food, 1334S(abst)
Gastric acid, inhibition of, sucrose polyester and, 761 Hydrogen production, in breath, amylose intake and, 1783
Gastric emptying, in bulimia nervosa, 114 3-Hydroxyisovaleric acid, as biotin status indicator, 951
Gastritis, Helicobacter pylori, carotenoids and vitamin E in, 101 Hypercholesterolemia
Gender. See Sex in children, fat intake changes in, 1357S(abst)
General practice. See Family medicine; Primary care physician depolymerized guar gum and, 107
Geriatric Food Behavior Instrument, 1316S(abst) familial, dietary adherence in, 1018
Geriatric population garlic and fish oil supplementation in, 445
biracial, food-frequency questionnaires in, 1307S(abst) psyllium in, 1524
cachectic, cytokine activity in, 876 Hyperlipidemia
coagulation factor VII in, dietary fat and fiber and, 732 diabetic risk in, n—3 fatty acid intake and, 1874
cognition in, nutrition and, 20 nutritional counseling in, 1939S
constipation and intestinal microflora in, inulin and lactose effects on, Hyperparathyroidism, in neonate, 771
1397 Hyperphagia, poststarvation, 717
dietary assessment in, 1168S, 1282S Hypertension
economic resources and, 1357S(abst) apolipoprotein E phenotype and diet in, 543
methods of, 1338S(abst) assessment of, 202S
in Puerto Rico, 1356S(abst) dietary intervention for, 1933S
times of food consumption and food choice in, 1364S(abst) effects of body mass and alcohol, nutrient, fiber, and caffeine intake to,
dietary recall in, 1315S(abst) 3388S
energy intake in, underestimation of, 1343S(abst) potassium intake and, 606S
fat intake by, 1300S(abst) prevention of, nonpharmacologic, 643S, 652S, 661S
food and nutrient intake in, 1304S(abst) sodium intake and
food behavior in, 1316S(abst) in children and adolescents, 618S
food-frequency questionnaires for, 1300S(abst), 1304S(abst), community-based intervention in, 661S
1311S(abst) dietary calcium and, 712S
hospital readmission in, 1714 genetic determinants of, 587S, 612S, 661S
splanchnic and whole-body leucine metabolism in, 489 INTERSALT study of, 626S
vitamin intake by, 67, 790, 1349S(abst) myocardial infarction and, 682S
Germany, dietary assessment validity in, 1295S(abst) other nutrient interactions in, 708S
Glucose, response to carbohydrates by, fat unsaturation and, 1427 pathophysiology of, 606S
Glucose intolerance, diabetic risk in, n—3 fatty acid intake and, 1874 public health policy and, 622S
Glucose turnover and oxidation, in hemodialysis, 128 salt sensitivity and, 587S, 612S
Glutamine, parenteral versus enteral, 977 trials of, 643S, 652S, 661S, 698S
Glycogen storage treatment of, 201S
abnormalities in, nocturnal cornstarch for, 1507 Hypogonadism, in Prader-Labhart-Willi syndrome, 1369, 1540(Editorial)
food intake and, 941
Grenada, dietary assessment in, 1166S Immune homeostasis, antioxidants and, 1901(Letter)
Growth, low birth weight and nutrition and, 1339S(abst) Immunity, cell-mediated, vitamin A supplementation and, in infants, 144
Growth and Health Study, 1297S(abst) Indonesia, vitamin A intake in, during lactation, 1320S(abst)
Growth hormone (GH), fat and protein oxidation and, 1384 Infant(s)
Guam, pregnant adolescent in, dietary assessment of, 1323S(abst) cell-mediated immunity in, vitamin A supplementation and, 144
Guar gum, hypercholesterolemia and, 107 Cryptosporidium infection in, malnutrition and, 149
hematologic status of, delayed umbilical cord clamping and, 425
Haiti, dietary assessment in, 1339S(abst) newborn, vitamin D deficiency in, 771
Hassidic Jews, dietary survey of, 1325S(abst) Infant nutrition. See also Neonatal nutrition
SUBJECT INDEX
breast-feeding in Kahweol, serum lipids and liver aminotransferases and, 519
addition of complementary food in, lactational amenorrhea and, 1403 Kenya, dietary assessment in, 1166S
child mortality and, 1062, 1070 Kinetic analysis, of folic acid metabolism, 53
colonic fermentation capacity and, 921 Korea
in Russia, 1341S(abst) dietary assessment in, 1361S(abst)
cereal in, iron bioavailability in, 916, 964 food-frequency questionnaire in, 1323S(abst)
formula feeding in nutrient intake in, seasoning consumption and, 1309S(abst)
calcium and phosphorus supplementation of, 921 Kuopio Breast Cancer Study, 1305S
iron in, 921 Kuwait, food consumption patterns in, 1355S(abst)
iron in
calcium and phosphorus supplementation and, 921 Lactation
in cereal, 916, 964 body fat in, 432
maternal anthropometry and, in Israel, 1731 bone mineral density in, 1738
parenteral, phenylalanine requirements in (pig), 984 urinary lactose during, 744
in Russia, 1341S(abst) vitamin A intake in, in Indonesia, 1320S(abst)
Infection, malnutrition and Lactational amenorrhea, complementary feeding and, 1403
in children, 1005 Lactitol, metabolic response to, 947
in West African infants, 149 B-Lactoglobulin, in human milk, 30
Inflammatory bowel disease Lactoovovegetarian, food-frequency questionnaires in, 1300S(abst)
dairy sensitivity and lactose malabsorption in (Commentary), 564 Lactose
nutritional intake in, Willett food-frequency questionnaire and, constipation and intestinal microflora and, in geriatric population, 1397
1299S(abst), 1352S(abst) urinary, during lactation, 744
pediatric, circulating antioxidants and, 1482 Lactose intolerance, daily milk ingestion in, 1502
Inflammatory mediators, in protein-energy malnutrition, in child, 1534 Lactose malabsorption, in inflammatory bowel disease (Commentary), 564
INFOODS, in dietary assessment, 1190S Letters to the Editor
Insulin, constipation and intestinal microflora and, in geriatric population, Adaptation and nutritional needs, 1570
1397 Antimetabolites and an optic neuropathy epidemic in Cuba, 1092, 1093
Insulin resistance Bioavailability of calcium supplements, 1898
in atherosclerosis Biochemical measures of thiamine deficiency, 1090, 1091
Editorial, 164 Biological variation of transferrin receptor and ferritin, 1897
study of, 79, 164 B-Carotene, malondialdehyde, and cystic fibrosis, 575, 576
dietary fat and, 79 Chromium supplementation and iron metabolism, 890, 891
protein intake and, in predialytic uremia, 1512 Destroying immune homeostasis in normal adults with antioxidant sup-
Insulin response plementation, 190i
to carbohydrates, fat unsaturation and, 1427 Do the metals in vitamin-mineral supplements produce undesirable
to sweet taste, in cephalic phase, 737 oxidations?, 1571
Insulin-like growth factor I (IGF-I), fat and protein oxidation and, 1384 Effective iron supplementation does not happen in isolation, 889
Interleukin(s), cachexia and, in elderly patients, 876 Effects of dietary palmitic and oleic acids on lipoprotein cholesteroi,
Interleukin-6, in protein-energy malnutrition, in child, 1534 170, 171
International Conference on Nutrition, 1198S Fatty acids and progression of coronary artery disease, 1088, 1090
International Lipid Trial, 1367S(abst) Jeng et al paper (Supplementation with vitamins C and E) a disappoint-
International Vitamin A Consultative Group, 1322S(abst) ment, 1899
INTERSALT study, 626S Linoleic acid content of test diets must be carefully monitored in
biochemical markers in, 1246S cholesterol studies, 1087, 1088
Intestinal lumen, polyamine concentrations in, 766 Pyridoxal 5’'-phosphate transfer in human placenta, 1571
Intestinal microflora, inulin and lactose effects on, 1397 Relation between choline and carnitine homeostasis, 574
Intestinal transit time, of fiber-supplemented enteral formula, 1840 Retrograded (RS;) but not uncooked (RS,) resistant starch lowers fecal
Intima-media thickness, carotid, lifestyle modification and, 1000 ammonia concentrations in healthy men, 167, 168
Iodine deficiency disorders, comparison of urinary iodine methods in, 1441 Role of isoflavones in cholesterol reduction by soy proteins in clinic, 166
Iron Validation of dietary assessment methods, 169
bioavailability of Vitamins may have different effects at different intakes, 577
calcium intake and, 1820 Leucine metabolism, splanchnic and whole-body, in young and elderly
in infant cereals, 916, 964 men, 489
rare earth elements and, 970 Leukemia, pediatric, nutritional status in, 95
infant formula fortified with, calcium and phosphorus supplementation Leukotrienes, n—3 fatty acid ingestion and, asthma and, 1011
of, 921 Licensing examinations, medical, nutrition on (Commentary), 568
nonheme, absorption of, calcium intake and, 1820 Lifestyle modification, carotid intima-media thickness and, 1000
Iron deficiency anemia Linoleic acid intake, in cholesterol studies, 1087(Letter), 1088(Letter)
hookworms and, in Zanzibari children, 153 Lipid level in blood. See also Hypercholesterolemia
in Jamaica, 831, 887 carbohydrate intake and, 314S
umbilical cord clamping and, 425 coffee diterpenes and, 519
Iron intake, in Russian women, 1367S(abst) dietary fat and cholesterol and, 1747
Iron metabolism, chromium supplementation and (Letter), 890, 891 studies of, 1893
Iron supplementation fiber intake and, 327S
in infant formula, calcium and phosphorus supplementation of, 921 garlic and fish oil supplementation and, 445
in Mexican preschoolers, 13 in human milk, 439
in pregnancy (Letter), 889 lipid intake and, 272S
weekly, in pediatric population, 1057 medium-chain triacylglycerols and, 41
Ischemic heart disease, antioxidant flavonols and, 1489, 1542(Editorial) thrombosis and, 1669S
Isoflavones, in soy protein cholesterol reduction (Letter), 166 Lipid peroxidation
Israel, infant nutrition in, maternal anthropometry and, 1731 atherosclerosis and, 121
Italy carotenoids and, in children with cystic fibrosis, 578(Erratum)
elderly in, dietary recall in, 1315S(abst) Lipoproteins
nutrition counseling and family medicine in, 1963S after NCEP Step 2 diet, 823, 885
1914 SUBJECT INDEX
coronary artery disease and, epidemiologic studies of, 1597S Mineral supplements, undesirable oxidations from, 1571(Letter)
desaturation and interconversion of dietary stearic and palmitic acids in, Minority populations, food-frequency questionnaires and, 1108S
451 Mitogenic proliferative response, carotenoids and, 871
high-density, regulation of, 1581S Monitored Atherosclerosis Regression Study (MARS), lifestyle modifica-
intake of tion in, 1000
assessment of, 1367S(abst) Morbidity, in family medicine, 1928S
thrombogenesis and, 1366S(abst) Morocco, food consumption patterns in, 1355S(abst)
low-density Mortality, of children, malnutrition and, 1062, 1070, 1080(Editorial)
antioxidant potential of, in endurance athletes, 1052 MRC National Survey of Health and Development, nonresponders to,
dietary fat saturation and, 1617S, 1628S 1341S(abst)
regulation of, 1581S Multiple Risk Factor Intervention Trial
medium-chain triacylglycerols and, 41 alcohol intake in, hypertension and, 338S
n—3 fatty acids and, 1611S, 1645S, 1655S background for, 191S
palmitic and oleic acid intake and (Letter), 170, 171 baseline food and nutrient intake in, 228S
postprandial blood lipids in
circadian variation of, 934 changes in, 272S
exercise and, in middle-aged women, 525 dietary carbohydrates and, 314S
viscosity and, 36 dietary fiber and, 327S
serum concentration of body mass in
diet and, 1329S(abst) food and nutrient intake and, 366S
dietary fat and cholesterol and, 1747 hypertension and, 338S
stearic acid, trans fatty acids and dairy fat effects on, 1419 measurement of, 203S
very-low-density smoking and, 374S
dietary soluble fiber and (guinea pig), 814 caffeine intake in, hypertension and, 338S
hepatic storage and transport of n—3 and n—6 polyunsaturated fatty data in
acids by (rat), 750 analysis of, 211S
Liver collection and coding of, 204S
aminotransferases in, coffee diterpenes and, 519 reliability of, 215S
fat synthesis in, carbohydrate overfeeding and, 1774 dietary adherence in, 289S
n—3 and n—6 storage and transport by (rat), 750 fiber intake in, hypertension and, 338S
Liver transplant, in children, malnutrition before, 1852 findings in, summary of, 184S
Liver transplantation, in child, long-term growth after, 534 food and nutrient intake during, 258S
Lumen, intestinal, fasting and postprandial polyamine concentration in, food groups in, 209S
766 hypertension in
Lycopene, in Helicobacter pylori gastritis, 101 alcohol intake and, 338S
assessment of, 202S
Maastricht Index, 1721 body mass and, 338S
Magnesium absorption, in postmenopausal women, boron and aluminum caffeine intake and, 338S
intake and, 803 fiber intake and, 338S
Magnesium metabolism, after burns, 1473 treatment of, 201S
Magnetic resonance imaging (MRI), of adipose tissue masses, 403 methods summary in, 184S
Malaysian food, in dietary recall instrument, 1314S(abst) nutritional adequacy in, 305S
Malnutrition nutritional assessment methods in, 196S
child mortality and, 1062, 1070, 1080(Editorial) nutritional intervention methods in, 199S
in children before liver transplant, 1852 participant selection for, 191S, 211S
Cryptosporidium infection and, in West African infants, 149 risk factor changes in, 194S
estimating ideal body weight in, 1314S(abst) smoking in, 202S, 203S, 211S
infection and, in children, 1005 body mass and, 374S
in Nigeria, 1331S(abst) structure of, 193S
protein quality and, 1309S(abst) Muscle function, in anorexia nervosa, refeeding and, 1845
protein-energy Myocardial infarction, sodium excretion and, 682S
in maintenance dialysis, 1544 National Cholesterol Education Program
pediatric, inflammatory mediators in, 1534 Rush Combined Fat Score versus, 1295S(abst)
recovery from, energy and protein metabolism during, 1517 Step 2 diets of, lipoprotein profiles after, 823, 885
Massachusetts Women’s Health Study, 1179S
McCollum Award Lecture: Protein-energy malnutrition in maintenance National Health and Nutrition Examination Survey (NHANES) III, under-
dialysis patients, 1544 reporting of energy intake in, 1203S
Meat intake, on food-frequency questionnaires, 1367S(abst) National Nutrition Monitoring and Related Research Program (NNMRRP),
Meat preparation methods, carcinogenesis and, 1331S(abst) 1198S
MEDFICTS, 1295S(abst) Nationwide Food Consumption Survey, 1356S(abst)
Medical licensing examinations, nutrition on (Commentary), 568 Native Americans, dietary assessment in, 1173S
Medical school, nutrition education in, 1558, 1559 NCEP. See National Cholesterol Education Program
Mediterranean diet, 1282S, 1366S(abst) Neonatal nutrition, parenteral, phenylalanine requirements in (pig), 984
Mediterranean population, alcohol intake in, 1324S(abst) Nepal, dietary assessment in, in children, 1322S(abst)
Memory. See also Dietary recall Netherlands
Metabolic rate, age and sex and, 895 dietary patterns in, 1360S(abst), 1967S, 1996S
Method of triads, in dietary validity studies, 1240S preventive medicine in, 1943S
Mexico, dietary assessment in, 1159S Neural tube defects, serum unmetabolized folic acid and, 1790
Middle-aged women, postprandia! lipemia in, exercise and, 525 Neuroendocrine function, sodium intake and, 594S
Milk, human. See also Lactation NHANES III (National Health and Nutrition Examination Survey IID,
B-lactoglobulin and ovalbumin in, 30 underreporting of energy intake, 1203S
lipids in, 439 NIDDM (non-insulin-dependent diabetes mellitus), protein turnover in,
Milk intake, in lactose intolerance, 1502 861
Mineral losses, exudative, in burns, 1473 Nigeria